Theglobeandmail

Published September 18, 2026 · Updated September 19, 2026

PharmAla Biotech Overhauls Auditor and Bolsters Investor Outreach - The Globe and Mail

Read the full story at Theglobeandmail

According to Spark, TipRanks' AI Analyst, MDMA is a Neutral. The score is held down primarily by weak financial performance—continued operating losses.